Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Promising cancer treatments were found, but the manufacturer closed.

The committee decided not to approve the drug due to low effectiveness and high risks.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Biosimilars lower costs but don't significantly improve access.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Imatinib can cause hair loss due to lichen planopilaris.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.